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Feasibility of Transdermal, Needleless Injections for Prevention of Pork
Carcass Defects
Abstract
A needle-free transdermal injection device was evaluated for effectiveness of vaccine delivery and for injection
site lesions. A total of 96 pigs were vaccinated for pseudorabies virus (PRV) and Mycoplasma hyopneumoniae
(M.hyo.). Pigs were divided into three groups; the first group served as unvaccinated controls, the second
group was vaccinated with conventional hypodermic needles, and a third group was vaccinated with a needle-
free, air-powered injection device. Pigs were tattooed on the neck to mark the injection sites. Blood samples
were collected from the pigs at 11−13 days and 23−25 days after injection, and the serological response was
measured. Injection sites were collected at slaughter and dissected to evaluate tissue damage. The results
showed that both injection methods produced similar serological responses in the vaccinated pigs and both
were significantly greater than the unvaccinated controls. The injection site examinations have shown no
lesions in any of the pigs. The results show the needle-free, transdermal injection device to be effective and
safe. Elimination of needles will prevent residual needle fragments in carcasses and associated carcass defects
from injection site lesions
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Summary and Implications
A needle-free transdermal injection device was
evaluated for effectiveness of vaccine delivery and for
injection site lesions. A total of 96 pigs were vaccinated for
pseudorabies virus (PRV) and Mycoplasma hyopneumoniae
(M.hyo.). Pigs were divided into three groups; the first
group served as unvaccinated controls, the second group
was vaccinated with conventional hypodermic needles, and
a third group was vaccinated with a needle-free, air-powered
injection device.
Pigs were tattooed on the neck to mark the injection
sites. Blood samples were collected from the pigs at 11−13
days and 23−25 days after injection, and the serological
response was measured. Injection sites were collected at
slaughter and dissected to evaluate tissue damage.
The results showed that both injection methods
produced similar serological responses in the vaccinated
pigs and both were significantly greater than the
unvaccinated controls. The injection site examinations have
shown no lesions in any of the pigs.
The results show the needle-free, transdermal injection
device to be effective and safe. Elimination of needles will
prevent residual needle fragments in carcasses and
associated carcass defects from injection site lesions.
Introduction
Pork carcass defects resulting from intramuscular
injection of vaccines and medications are a well-recognized
problem in the meat industry. However, a more serious
problem to the meat industry is the presence of broken
needles and needle fragments. Needle fragments are not
easily identified by metal detectors due to alloy composition
of the needles, fragment size, and orientation to the detector.
Needle fragments in pork carcasses are identified by metal
detectors in less than 10% of the cases when they are
present. Thus, the potential exposure of consumers to metal
fragments in pork products is a serious concern.
A viable alternative for vaccinations is a needle-free,
transdermal injection, which does not use hypodermic
needles. A device recently developed by Felton Medical Inc.
(Lenexa, KS) delivers vaccines through the skin using
compressed air. However, the immunological response and
the degree of injection site damage that occurs in pigs from
the transdermal injection system had not been determined.
This project was designed to evaluate the effectiveness
of needle-free, transdermal injections for delivery of
vaccines in pigs and to compare injection site damage
between the needle-free and conventional hypodermic
needle injections.
Objectives
The main objectives of this study were:
a.  Evaluate the delivery effectiveness of a needle-free,
transdermal injection system for swine using a common
viral (pseudorabies) vaccine and a common bacterial
(Mycoplasma hyopneumoniae) vaccine.
b.  Assess and compare muscle and tissue damage resulting
from conventional hypodermic needle injections and needle-
free, transdermal injections.
Materials and Methods
A total of 130 pigs were selected from the Iowa State
University Bilsland Memorial Swine Breeding Farm at
Madrid, IA. Two weaning groups were selected for two
separate trials (replications). Pigs were bled, tagged,
tattooed, and randomly assigned to treatment groups at 4−5
weeks of age. Tattoos were placed on the left neck to
provide a marker for the injection sites. The three injections
for each pig were given 1 in. from the tattoo in a different
direction each time to form a triangle (anterior, posterior,
and ventral) of injection sites. Treatment groups for the pigs
included controls (no injection), hypodermic needle
injection and needle-free transdermal injection. For
hypodermic needle injections, an 18-gauge x 5/8 in. (first
vaccination) or 1 in. (second and third vaccinations) needle
was used for intramuscular deposition of the vaccines.
Needles were changed at least every six pigs.
For the needle-free injections, an air-powered device
currently under development for commercial applications by
Felton International Inc. was used. Company personnel
performed injections. Operating air pressure was adjusted
according to pig size to achieve the appropriate depth of
injection.
The pigs were vaccinated with two doses of M.hyo.
vaccine (Respisure; Pfizer Animal Health) at 5−6 weeks of
age and again 2 weeks later, and with pseudorabies vaccine
(PrVac+; Pfizer Animal Health) at 9−10 weeks of age.
Blood samples were collected before vaccination, at 11−13
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days after the second mycoplasma vaccination and 23−25
days after the PRV vaccination.
For the M. hyo., the immune response was evaluated by
Tween 20 ELISA for M. hyo. antibodies and recorded as
optical density values. For PRV, a commercial ELISA
(IDEXX, Portland, ME) was used by the Iowa State
Veterinary Diagnostic Laboratory to determine serological
response and results were recorded as S/P ratios.
Injection sites were observed and palpated after the
injections and at each time of blood collection. Injection
sites were removed from carcasses at slaughter and
dissected to assess and compare tissue damage.
All data were subjected to statistical analysis to
determine statistical significance and validate treatment
differences.
Results and Discussion
The results from antibody analyses showed that all the
pigs were negative for both M.hyo. and PRV before
vaccination. The results of the vaccinations with the two
methods are shown in Table 1. Both injection methods
resulted in significantly increased serological response
compared to controls. In addition, there was no significant
difference between the two injection methods. Therefore,
the needle-free injection system is equally effective
compared to the conventional hypodermic needle injection
for vaccinations of M.hyo. and PRV.
Evaluation of injection sites on live pigs showed about
15% of the transdermal sites to have a transient skin
thickening shortly after injections. Less than 1% of the
needle injected sites showed similar thickening. This was
observed only at 2 days after injection. Evaluation of
injection sites after slaughter showed 3 lesions in 117 sites
for the needle-free injections and 3 in 114 sites for the
needle injections. The small, mild lesions observed were of
no consequence for meat quality. No abscesses or
granuloma were observed in any pigs.
The results of this study demonstrate that the needle-
free injection system is effective for delivery of M.hyo. and
PRV vaccines. Further, no tissue damage was observed for
the conventional hypodermic needle injections, but these
were not expected under the controlled conditions of this
experiment. These defects are well documented for
commercial pork carcasses.
It is clear that the needle-free injection system will
eliminate all residual needles and needle fragments from
pork carcasses and it seems likely to reduce injection site
lesions resulting from contaminated needles, as well.
To fully evaluate the needle-free injection system,
additional studies with more and different vaccines
delivered transdermally should be conducted. The needle-
free, transdermal injection system for delivery of vaccines
has excellent potential for use in swine production systems.
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   Table 1.  Immune response to injections.
Trial Injection type M.hyo.-O.D. values PRV-S/P ratios
Test 1 Test 2
1 Control 0.038 0.073 0.016
Needle 0.515 0.426 1.124
Needle-free 0.559 0.407 1.259
2 Control 0.075 0.047 0.037
Needle 0.377 0.259 2.116
Needle-free 0.449 0.241 1.874
